Read + Share
Amedeo Smart
Independent Medical Education
Hall KH, Brooks A, Waller EK. Overcoming TKI resistance in a patient with chronic myeloid leukemia using combination BCR-ABL inhibition with asciminib and bosutinib. Am J Hematol 2021 May 10. doi: 10.1002/ajh.26231.PMID: 33971041
Email
LinkedIn
Facebook
Twitter
Privacy Policy